Wordt geladen...
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells
Checkpoint kinase Chk1 is constitutively active in many cancer cell types and new generation Chk1 inhibitors show marked antitumor activity as single agents. Here we present a hitherto unrecognized mechanism that contributes to the response of cancer cells to Chk1 targeted therapy. Inhibiting chroni...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3870284/ https://ncbi.nlm.nih.gov/pubmed/24072747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|